Market Access News | pharmaphorum

News

PTC Therapeutics' treatment for the rare disease PKU, Sephience, will launch in its first market next month after getting EU approval.

News

AZ and Daiichi Sankyo have claimed FDA approval for Datroway in lung cancer after switching indications for the TROP2-directed drug.

News

Republican Senator Bill Cassidy says tomorrow's meeting of the CDC's vaccines advisory committee should be delayed as the new members may be biased.

News

GSK's drug for severe itching in patients with autoimmune liver disease PBC is now under review in the EU and US, as Mirum Pharma tries to catch up.

News

Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.

News

Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.